Cargando…
The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Extrapulmonary Small Cell Carcinoma
Small cell carcinoma is a type of highly aggressive poorly differentiated neuroendocrine tumor that can arise from multiple organs, including but not limited to bronchial tissue, pancreas, gastrointestinal tract, and genitourinary system. The most commonly studied type is small cell lung cancer (SCL...
Autores principales: | Aly, Ragia, Gupta, Sachin, Potdar, Rashmika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325398/ https://www.ncbi.nlm.nih.gov/pubmed/32617246 http://dx.doi.org/10.7759/cureus.8862 |
Ejemplares similares
-
Evolving Paradigms in the Management and Outcomes of Sarcomatoid Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors
por: Aly, Ragia, et al.
Publicado: (2020) -
Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases
por: Wang, Chunyu, et al.
Publicado: (2023) -
Hepatocellular Carcinoma Presenting With Inferior Vena Cava Tumor Thrombus Extending to the Right Atrium: A Case Report
por: Aly, Ragia, et al.
Publicado: (2020) -
Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer
por: Rittberg, Rebekah, et al.
Publicado: (2022) -
An online tool for survival prediction of extrapulmonary small cell carcinoma with random forest
por: Zhang, Xin
Publicado: (2023)